RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Leveraged Buyouts

A collection of news and information related to Leveraged Buyouts published by this site and its partners.

Top Leveraged Buyouts Articles

Displaying items 12-22
  • Wall Street Sees More Shakeups Ahead After Comcast-TW Cable Deal

    Wall Street has been generally high on Comcast Corp. in recent months, but the immediate reaction to its mega-merger with Time Warner Cable was more focused on questions than applause. Comcast shares were down $2.28 at the close of trading Thursday to...
  • Allergan co-founder speaks out against Valeant takeover

    The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders. Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to...
  • Botox-maker Allergan rejects takeover bid from Valeant

    Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders. Last month, the Irvine drugmaker received an...
  • Ackman, Valeant partner in bid to buy Botox maker Allergan

    Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox. Ackman and Valeant Pharmaceuticals International Inc. have already...
  • Ackman and Valeant make bid for Allergan

    Ackman and Valeant make bid for Allergan
    Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle treatment. Valeant will...
  • Allergan adopts 'poison pill' defense in Valeant takeover bid

    Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman. The Irvine company's...
  • Jos. Bank to be acquired by Men's Wearhouse for $1.8 billion

    Jos. Bank to be acquired by Men's Wearhouse for $1.8 billion
    Jos. A. Bank Clothiers finally liked the look of Men's Wearhouse's takeover offer as the Hampstead-based retailer accepted a $1.8 billion buyout Tuesday. The deal would pay Bank's stockholders $65 a share cash, $10 more than Men's Wearhouse initially...
  • On thin ice

    On thin ice
    Before they began practice one recent morning in Salt Lake City, Olympic bronze medalist Lana Gehring of Glenview and four other elite speedskaters had to assemble protective pads around the walls of a municipal rink. Working in tandem, the skaters...
  • When Buffett gets Heinz, he'll also add Burger King CEO Hees

    Fast food giant Burger King Worldwide Inc. said it will lose its chief executive Bernardo Hees to H.J. Heinz Co. once billionaire financier Warren Buffett wraps up his acquisition of the ketchup company with 3G Capital. Corporate poaching this...
  • Rumors of buyout talks drive Safeway stock gains

    Safeway Inc. shares have climbed for two straight days on speculation of a buyout offer just weeks after the grocery giant deflected another potential takeover. Buyout rumors erupted this week on reports that private equity firm Cerberus Capital...
  • AT&T to acquire Leap Wireless in $1.2-billion deal

    AT&T to acquire Leap Wireless in $1.2-billion deal
    Seeking a foothold in the competitive prepaid wireless market, AT&T Inc. has agreed to acquire Leap Wireless International Inc. in a deal valued at about $1.2 billion. AT&T, the nation's second-largest wireless carrier, had been rumored to be in talks...